In a groundbreaking study published in late March/early April 2026, researchers at the Weizmann Institute of Science in Israel successfully engineered a species of tobacco (Nicotiana benthamiana) to produce five different psychedelic compounds simultaneously.
Here is a summary of the key details from the New Scientist report:
1. The "Trippy" Tobacco Plant
The researchers successfully reconstructed the complex biochemical pathways required to produce five naturally occurring psychedelic tryptamines in a single plant. These include:
* Psilocybin and Psilocin: Found in "magic" mushrooms.
* DMT (N,N-Dimethyltryptamine): Found in various plants used in Ayahuasca.
* Bufotenin and 5-MeO-DMT: Naturally secreted by the Sonoran Desert toad (Incilius alvarius).
2. How They Did It
* Genetic Engineering: The team identified the specific genes used by fungi, plants, and animals to create these substances and inserted them into the tobacco plant.
* Pathway Reconstruction: Nicotiana benthamiana—a relative of commercial tobacco often used as a "lab rat" in plant biology—was chosen because its genetics are easy to manipulate. The plant was able to use its own internal resources to fuel the production of these foreign molecules.
* Novel Analogs: Beyond just replicating natural drugs, the scientists were able to create halogenated analogs—modified versions of these psychedelics that do not exist in nature—which may have unique therapeutic properties.
3. Why This Matters
The primary goal of the research is not recreational, but pharmaceutical:
* Sustainable Production: Current methods of obtaining these drugs (extracting them from rare mushrooms or toads) are often unsustainable or ecologically damaging. Lab-grown plants could provide a consistent, "green" factory for medicine.
* Drug Discovery: By making it easier to produce and modify these compounds, scientists can more efficiently study their potential for treating depression, PTSD, and other mental health conditions.
* Scalability: Tobacco is a hardy, fast-growing crop. Using plants as "bioreactors" is often cheaper and more scalable than using complex chemical synthesis or vats of genetically modified yeast.
4. Limitations
While the plant produced all five compounds, they were produced in varying concentrations because the different pathways competed for the same biological precursors within the plant. Additionally, while this is a major leap for biotechnology, the researchers emphasized that these are experimental plants intended for controlled medical research, not for agricultural or public use.
https://www.newscientist.com/article/2521338-tobacco-plant-altered-to-produce-five-psychedelic-drugs/
